Cargando…
Interleukin-6 and leptin as markers of energy metabolicchanges in advanced ovarian cancer patients
The progression of the neoplastic disease is characterized by specific alterations of energy metabolism and by symptoms like fatigue, anorexia, nausea, anaemia, immunodepression and poor performance status (PS). The main cause of these symptoms and metabolic abnormalities is the chronic action of pr...
Autores principales: | Macciò, Antonio, Madeddu, Clelia, Massa, Daniela, Astara, Giorgio, Farci, Daniele, Melis, Gian Benedetto, Mantovani, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516542/ https://www.ncbi.nlm.nih.gov/pubmed/18624749 http://dx.doi.org/10.1111/j.1582-4934.2008.00408.x |
Ejemplares similares
-
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
por: Macciò, Antonio, et al.
Publicado: (2021) -
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
por: Madeddu, Clelia, et al.
Publicado: (2018) -
Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome
por: Mantovani, Giovanni, et al.
Publicado: (2013) -
Laparoscopic management of a giant mucinous benign ovarian mass weighing 10150 grams: A case report
por: Sanna, Elisabetta, et al.
Publicado: (2020) -
Correspondence on “Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer” by Polen-De et al
por: Maccio, Antonio, et al.
Publicado: (2022)